Introduction
Tan1, the human homolog of the Drosophila gene NOTCH1 (hereafter referred to as NOTCH1), was initially described in studies associated with T cell acute lymphoblastic leukemia/lymphoma (T-ALL) having a recurrent translocation occurring between chromosomes 7 and 9 locus q34; q34.3.
1,2
The wild-type NOTCH1 is expressed in most tissues but is present in high levels in the thymus and brain. 2, 3 The wildtype gene encodes a 2555 amino acid type 1 transmembrane receptor protein larger than 300 kDa (see Figure 1 ) with known domains described previously for the Drosophila homologs. 2, 4 The breakpoints occurring in the T-ALL lines all occur within a single intron resulting in a truncated form of the gene which overexpresses the 3Ј end of NOTCH1. 2 The truncated transcripts lacking the external epidermal growth factor-like and lin-12 repeats vary from approximately 100 to 125 kDa in size. 4 The ⌬E molecule includes the transmembrane domain of the molecule and is localized to the nuclear membrane whereas the ICN localizes to the nucleus of cells. 5 The subcellular localization of ⌬E at the nuclear membrane when compared to nuclear localization ICN suggests that there may be differences in the level of potency for the oncogenicity and transactivation activities of these intracellular forms of NOTCH1. 5 However, in transient transfections ⌬E and ICN transactivate to similar extents in 293 cells and have similar oncogenic properties in transformation assays in mice. 4, 6 Similarly, analysis of NOTCH1 by removal of extracellular sequences has subsequent consequences on differentiation in a manner consistent with exposure of full length NOTCH1 to its ligand. [7] [8] [9] [10] [11] These findings were consistent with the model that truncation of NOTCH1 can lead to constitutive activation of the intracellular domain and upregulation of RBP-J responsive genes. Therefore, signaling by NOTCH1 can be mediated by its association with RBP-J and potential other factors acting at the promoters. [12] [13] [14] [15] Genetic studies have also suggested a functional association with these two molecules in that studies in Drosophila and C. elegans encoding homologs of mammalian NOTCH1 indicate that RBP-J acts downstream of NOTCHI.
which contains a tryptophan residue at amino acid 1767, considered important for the interaction and ankyrin repeats. 5 The tryptophan residue Trp 1767 lies 10 amino acids internal to the transmembrane domain. 26 Constructs without the RAM domain activate promoter elements as efficiently as constructs with an intact RAM domain 5, 22 suggesting that the association can occur without an intact RAM domain resulting in transactivation.
The EBNA2 viral transactivator is incapable of binding to DNA by itself and requires the association with RBP-J for targeting the promoter elements. EBNA2 is essential for EBV immortalization of human primary B lymphocytes and the association of RBP-J and EBNA2 is a critical component of the immortalization process since viral recombinants mutated in the RBP-J binding site of EBNA2 do not transform human primary B cells in vitro. 27 EBNA2 also associates with numerous components of the basic transcriptional machinery and also other transcription factors that include PU.1 and AML1. 28 Moreover, its interaction with RBP-J is essential for the immortalization process. 27 The similarity between EBNA2 and NOTCH1 in their association with RBP-J prompted us to further extensively investigate these associations comparing the interactions seen in T cells with a number of B cell lines including primary human B lymphocytes. This would allow us to evaluate the ability of EBNA2 to compete with NOTCH1 for binding to Schematic showing the full length NOTCH1 protein with the identified extracellular and intracellular domains. The EGF-like repeats and the Lin repeats are positioned extracellular to the transmembrane domain. Two cysteines are potentially involved in the formation of disulfide bridges. The cdc 10 (Ankyrin) repeats, two nuclear localization signals N1 and N2, the PEST and OPA sequences are intracellular domains. 4, 6 The ⌬E construct contains the leader peptide, the transmembrane domain and the intracellular region of NOTCH1 and localizes to the nuclear membrane. The ICN construct lacks the leader peptide and the transmembrane region and localizes to the nucleus. The ⌬E TAR contains the same sequence as ⌬E but is deleted for the ankyrin repeats.
5 T3 and T6 are regions used in the production of antibodies against NOTCH1.
RBP-J in B cells. The association of RBP-J and NOTCH1 in B and T cells was investigated and the results of these studies show that there is a distinct difference in the level of association between RBP-J and NOTCH1 in B cells as compared to that observed in T cells. The studies were further investigated in primary lymphocytes, which also demonstrated that there was little or no RBP-J associated with NOTCH1 in primary human B cells as distinct from primary human T cells. The association of NOTCH1 with RBP-J in B cells was undetectable or negligible in all B cell lines and primary B lymphocytes. However, NOTCH1 strongly associates with RBP-J in T cell lines as well as primary T lymphocytes. These results suggest that EBNA2 may have an accessible pool of RBP-J in human primary B cells therefore activating RBP-J responsive promoters, whereas, much less RBP-J available in T cells complexed with NOTCH1 and requires EBNA2 to compete with activated NOTCH1 in human primary T cells for access to responsive promoters. Additionally, interaction of RBP-J with EBNA2 is essential for EBV immortalization of B cells. Hence, the availability of RBP-J for interaction with EBNA2 in T cells is most likely a critical step in the immortalization process.
Materials and methods

Antibodies and cell lines
The antibodies anti-T3 (amino acids 1763-1877) and TC (amino acids 2277-2470), and anti-RBP-J (amino acids 1-44) against the amino-terminal portion of RBP-J used for immunoprecipitation of the intracellular forms of NOTCH1 and RBP-J, respectively, have been described previously. 5, 29, 30 GST-fusion protein GST-ICN and the full length RBP-J, GST-RBP-J, were used to immunize rabbits for production of rabbit polyclonal antiserum (Cocalico, Reamstown, PA, USA).
Cell culture reagents were obtained from BRL, Life Technologies, Bethesda, MD, USA. All cell lines were cultured at 37°C under 5% CO 2 . SUP-T1, a human T lymphoblastic cell line containing two copies of a balanced (7;9)(q34;q34.3) chromosomal translocation and no normal chromosome 9 31 was grown in RPMI 1640 supplemented with 10% fetal calf serum. Akr is derived from a murine spontaneous T cell tumor Leukemia and T6E is a human T cell tumor line produced by overexpression of the ⌬E construct. 6 These cell lines were grown in RPMI supplemented with 20% fetal calf serum and interleukin-2 (4 units/ml). The B cell line BL41 and BJAB are EBVnegative Burkitt's lymphoma cell lines; BL41/B95-8 was derived from BL41 by infection with a transforming strain of EBV B95-8; 30 IB4 is an EBV infected lymphoblastoid cell line (LCL) previously established and LCL1 is a newly derived human primary B cell line infected with EBV. 30 All B cell lines were grown in RPMI 1640 supplemented with 10% fetal bovine serum from Gemini Bio-products, gentamicin 20 g/ml (Gemini-Bio-Products, Calabasas, CA, USA) and penicillin/streptomycin (BRL-GIBCO) 5 U/ml and 5 g/ml, respectively.
cDNA expression constructs
The cDNA constructs NOTCH1 (codons 1-2555), ⌬E (codons 1-22 fused to codons 1673-2555), ⌬E TAR (a subclone of ⌬E with a deletion removing codons 1858-2206), and ICN (codons 1770-2555) have been previously described. 5, 6 The EBNA2 cDNA cloned into pSG5 vector was described previously. 30 
Production of GST-fusion polypeptides and in vitro binding assays
Expression and purification of GST-NOTCH1 ankyrin repeat 5 (codons 1872-2123) and GST-RBP-J fusion proteins have been described. 5, 30, 32 After subcloning into pGEX-2TK (Pharmacia, Piscataway, NJ, USA), GST-RBP-J and GST-NOTCH1 ankyrin repeat fusion proteins were expressed in E. coli and purified on glutathione-Sepharose beads (Pharmacia). 5, 30, 32 NOTCH1 cDNAs in pSP72 (Promega, Madison, WI, USA) and RBP-J3 cDNA in pSG5 were transcribed and translated in vitro in the presence of 35 S-methionine (NEN-Dupont) using rabbit reticulocyte lysates (Promega). 35 S-methioninelabeled polypeptides were stored at −80°C. Binding of in vitro translated polypeptides to GST-fusion proteins were performed under conditions described by Jarriault et al. 33 Briefly, 5 l of labeling mix containing polypeptides translated in vitro were diluted into 0.5 ml of ice-cold 25 mM Hepes, pH 7.5, containing 0.5% NP-40, 100 mM KCl, 5 mM MgCl 2 , 5 mM DTT, 0.2 mM EGTA, 10 g/ml aprotinin, 10 g/ml leupeptin, h and 1 mM phenylmethylsulfonyl fluoride (binding buffer). This mixture was precleared by incubation with 50 l of GSTglutathione Sepharose beads at 4°C with mixing for 60 min. After removal of the beads by brief centrifugation in a microfuge, the remaining supernatant was divided into two aliquots of 0.25 ml and incubated with either GST fusion protein-glutathione Sepharose beads or an equivalent volume of GST-glutathione Sepharose beads at 4°C with mixing for 60 min. Beads were washed twice with binding buffer, once with binding buffer containing 200 mM KCl, and once more with binding buffer, and then boiled in SDS-PAGE loading buffer. 35 S-labeled polypeptides were separated by SDS-PAGE in 10% gels and visualized by fluorography.
Immunoprecipitation
Unless otherwise noted, all incubations described below were performed at 4°C with mixing. To prepare immunoprecipitates with polyclonal rabbit antibodies, cells were washed twice with ice-cold phosphate-buffered saline and then lysed in ice cold 25 mM HEPES, pH 7.5, containing 1% NP-40, 70 mM KCl, 20 mM NaF, 2 mM sodium orthovanadate, 2 mM sodium molybdate, 0.2 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, and 10 g/ml leupeptin (lysis buffer). After 30 min on ice, insoluble material was removed by centrifugation at 4°C and 14 000 g for 15 min. Supernatants were divided into two aliquots that were incubated with 3 l of rabbit serum or 10 l of affinity purified rabbit antibody for 60 min on ice. Twenty-five l of Protein A Sepharose beads (Sigma, St Louis, MO, USA) were then added and the incubation allowed to proceed for an additional 60 min at 4°C with mixing. Beads were washed four times with lysis buffer and bound polypeptides eluted by boiling in SDS-PAGE buffer. Immunoprecipitated polypeptides were then separated by SDS-PAGE and analyzed by Western blotting.
Isolation of human primary B and T lymphocytes
Four hundred and twenty milliliters of human whole blood was drawn from a healthy adult volunteer in heparinized syringes. The whole blood was fractionated by Lymphoprep gradient (GIBCO-BRL) for 30 min at 1800 r.p.m. at 20°C. The lymphocyte fraction in the buffy coat was removed, washed three times in RPMI-1640 supplemented with 5% fetal bovine serum. The crude B and T cell fractions were then separated by two rounds of rosetting with sheep RBCs (Bio Whittaker, Walkersville, MD, USA) overnight. The B and T cells were fractionated by Lymphoprep (GIBCO-BRL) gradient at 20°C, 1800 r.p.m. for 30 min. The B cells were collected from the buffy coat and the remaining white blood cells containing the crude T cell preparation were collected from the pellet. The remaining RBCs were lysed with Tris-buffered ammonium chloride pH 7.4. All lymphocytes were washed three times with 50 ml of RPMI-1640 and resuspended in RPMI-1640 supplemented with 10% fetal bovine serum.
Northern blot analysis
BL41, BL41/B958, IB4 and LCL1 are B cells; SupT1 and Akr are T cells. One hundred milliliters of exponentially growing cells were harvested and total RNA isolated as described previously. 30 The total RNA was used to prepare the polyA RNA as described by the manufacturer's directions using the Oligotex mRNA maxi kit purchased from Qiagen (Santa Clarita, CA, USA). Ten micrograms of polyA mRNA from each sample was used and fractionated on a 1% formaldehyde ME agarose gel in 0.5 × TBE buffer system. The polyA mRNA was transferred to GeneScreen Plus nylon membrane (NEN-Dupont) and baked for 1 h at 80°C. The nylon was then subsequently used for hybridizing probes for CD23, HES1 and GAPDH. For HES1 mRNA identification the cDNA for HES1 was linearized and labeled with 32 P-dCTP from NEN-Dupont. Labeled probe was separated from unincorporated label using the Stratagene NucTrap column system. The nylon membrane was incubated at 65°C for 3 h in pre-hybridization solution, 30 the labeled HES1 probe added and incubated at 65°C for 18 h. The probe was then removed and the nylon membrane washed twice at 10 min intervals in 2 × SSC at room temperature, twice at 65°C for 30 min in 1% SDS, 2 × SSC and twice at room temperature in 0.1 × SSC for 30 min. The labeled nylon membrane was then placed on a damp 3MM Whatman paper and wrapped in Saran wrap and exposed to X-ray film (NENDupont, Boston, MA, USA). The nylon was reprobed by stripping in 1% SDS and 0.1 × SSC at 95°C for 20 min, rinsed in 0.1 × SSC, pre-hybridized for 3 h at 65°C and hybridized with the new probe at 65°C for 18 h. The process was repeated for each new probe.
Quantitation of the HES1 and GAPDH signals was done using arbitrary counts in NIH Image software (SCION Image) to obtain relative numbers for induction of the signals in the EBV infected B cells and T cells overexpressing truncated NOTCH1.
Results
The EBV transactivator EBNA2 competes with the intracellular domain of NOTCH1 for interaction with RBP-J
Previous observations that NOTCH1 activates the major EBV latent promoter Cp1 5, 22 indicated that the EBNA2 protein may have to compete with NOTCH1 for available RBP-J sites on cellular and viral promoters. To test this possibility, we used two GST fusion proteins GST-J and GST-NOTCH1 containing the full length RBP-J and the intracellular region of NOTCH1, respectively. In Figure 2a in vitro translated 35 Slabeled NOTCH1 and EBNA2 were incubated with GST-J with NOTCH1 amounts remaining constant (5 l in vitro translated 35 S-labeled product) and the levels of EBNA2 increasing from 2 l to 5 l (in 1 l increments). The results demonstrated that the level of NOTCH1 bound to GST-J continually decreased as the amount of EBNA2 was increased greater than that for NOTCH1 (Figure 2a, lanes 5-8) . The alternative experiment in Figure 2b used 5 l of in vitro translated 35 S-labeled RBP-J and increasing amounts of EBNA2 added from 2 l to 5 l (1 l increments) bound to GST-NOTCH1. The results again demonstrated that EBNA2 competed with NOTCH1 for binding to RBP-J in vitro suggesting a greater affinity for RBP-J than NOTCH1 (Figure 2b , lanes 5-8). However, further experiments will have to be done with purified proteins to determine the affinities of EBNA2 and NOTCH1 for interaction with RBP-J. In both cases the 35 Slabeled EBNA2 competed for interaction with RBP-J efficiently after 35 S-labeled in vitro translated product was added to the reaction. EBNA2 did not interact with GST-NOTCH1 as shown in Figure 2b , upper band but competed and bound with GST-J quite efficiently (see Figure 2a , upper band) as the levels of bound NOTCH1 decreased in the reaction. The levels of 35 S-labeled RBP-J in Figure 2b decreased as the amount bound to GST-NOTCH1 is competed away by the increased levels of in vitro translated EBNA2 in the reaction. Analysis of this competition in an in vivo assay under physiological conditions would be interesting if it was possible using an expression transient system. The ability of EBNA2 to compete with NOTCH1 is an important point and suggests a similar interacting domain and a possible mechanism for EBV-mediated promoter activation driving cell proliferation. However, these results are only preliminary and further experiments in vitro with purified proteins will provide a more thorough understanding of the specific affinities for RBP-J.
Intracellular forms of NOTCH1 associates with RBP-J in T cell lines but is undetectable in B cell lines
To investigate the role of RBP-J in B cell infection and immortalization by EBV we attempted to look at the levels of RBP-J associated with NOTCH1 in human B cell lines as would compare with the T cell lines. We chose two T cell lines known to express detectable levels of NOTCH1 as determined previously. 5 The B cell lines infected with EBV included a Burkitt's lymphoma cell line BL41 infected with a transforming EBV strain and two LCLs, IB4 a long-term established lymphoblastoid cell line (LCL) and LCL1 a recently established human primary B lymphoblastoid cell line. The results demonstrated that after immunoprecipitation using the anti-NOTCH1T6 (Figure 1 ) rabbit polyclonal antiserum from 50 million cells, no detectable levels of RBP-J were observed Leukemia in the B cell lines (Figure 3a , panel A) compared to the two T cell lines where RBP-J is seen associated with NOTCH1 (Figure 3a, panel B) . Therefore, the amount of RBP-J from the total cellular pool associated with NOTCH1 in B cells is less than that associated with NOTCH1 in T cells. As observed before only the lower form of RBP-J is associated with the intracellular NOTCH1 from immunoprecipitation analysis. 5 The RBP-J antiserum used recognizes the two forms of RBP-J differing in their amino terminal domain shown in the lysate (Figure 3a, panels A and B) . 5 To further investigate whether or not the detection of RBP-J associated with intracellular NOTCH1 was due to the specific antiserum used against the intracellular region of NOTCH1 or that levels of NOTCH1 were lower in B cells than T cells, we obtained serum from rabbits injected with a GST fusion of the region of NOTCH1 that included the ankyrin repeats (Figure 1 ). This construct may potentially have epitopes that allow for detection and antibody production as compared to that of the TC domain of NOTCH1. In all cases, we observed that in the two T cell lines detectable levels of RBP-J coimmunoprecipitated with the intracellular domain of NOTCH1 from 50 million cells with levels of approximately 1%. However, in the B cell lines investigated, using both EBV uninfected and infected cell lines (BL41 and BL41/B95-8, respectively), no RBP-J was observed in a co-immunoprecipitation with anti-NOTCH1 rabbit serum (see Figure 3b 
Co-immunoprecipitation analysis using antibody against RBP-J indicates that intracellular NOTCH1 associates with RBP-J in T cell lines and at negligible levels in B cell lines
We attempted to do the reciprocal experiment using rabbit polyclonal antiserum against the full length RBP-J to determine if very small quantities of intracellular NOTCH1 might be associated with RBP-J in B cells. Moreover, the association may be difficult to detect after immunoprecipitation with the anti-NOTCH1 polyclonal serum and Western blotting with anti-RBP-J polyclonal serum. It was also possible that the anti-serum for intracellular NOTCH1 would be more sensitive than that used for RBP-J allowing for detection of small quantities of NOTCH1 associated with RBP-J compared to detection of RBP-J. In this experiment we used 1% of the control lysate and immunoprecipitated from lysate of 50 million cells as before. In all T cell lines used including Jurkat, T6E and Akr the intracellular form of NOTCH1, or p120 molecule, coimmunoprecipitated with RBP-J at relatively high levels based on a crude comparison of the lysate and the immunoprecipitated NOTCH1 p120 band (Figure 4a) . Additionally, in all the T cell lines a band migrating approximately 110 kDa was observed below the p120 band in all the T cell lines 
Figure 4
Immunoprecipitation analysis using rabbit polyclonal antiserum raised against the full length GST-RBP-J. Panel a shows the T cell lines and panel b the B cell lines. Fifty million cells were lysed and 3 l of rabbit polyclonal serum used for immunoprecipitation. Lanes L represent lysate from each cell line, NS the normal rabbit serum control lane and IP the immunoprecipitation lane from each analysis. The membranes were immunoblotted for detection of the NOTCH1 protein using anti-NOTCH1 polyclonal rabbit serum. The lower band below the p120 signal for intracellular NOTCH1 was not seen in the B cells and may represent another cleaved product in T cells or a degradation product of the p120 molecule.
( Figure 4a ). This 110 kDa band and other specific bands were also observed of lower molecular weight and is possibly due to breakdown of the p120 intracellular NOTCH1. In the B cell lines, little or no intracellular NOTCH1 was seen co-immunoprecipitated with RBP-J, as seen in Figure 4b 
RBP-J associates with NOTCH1 in human primary T cells but is undetectable in human primary B cells
The observations above prompted us to investigate further the association of NOTCH1 and RBP-J at the level of human primary cells. This would indicate whether or not this observed interaction in T cells occurred prior to transformation of these T cell lines. Primary lymphocytes isolated from three different donors (each donor represented by Figure 5 panel a, b and c) was collected and the B and T cell fractions were separated and washed extensively in media. Preparations of 50 million primary crude B cells and T cells were obtained from each donor and immunoprecipitated using rabbit polyclonal antiserum raised against the GST-RBP-J molecule. Western blotting with polyclonal rabbit serum against intracellular NOTCH1 (Figure 1 ), demonstrated that little or no signal was seen in primary B cell co-immunoprecipitation analysis whereas in the T cell analysis signals for p120 were seen in the co-immunoprecipitation lane (see Figure 5 a-c) . In panel a, b and c the blots were probed with rabbit polyclonal serum raised against a GST fusion protein of intracellular NOTCH1
Figure 5
Immunoprecipitation analysis in human primary B and T cells. Fifty million human primary lymphocytes were used for the analysis. Panels a, b and c represent three individual whole blood donors. The arrow on the right indicates the position of the NOTCH1 protein p120 signal. Lanes L, NS and IP represent the 1% lysate, normal rabbit serum control and the immunoprecipitation analyses, respectively. NOTCH1 signals were only seen in the crude T cell preparations. Multiple bands were seen in the B cell lysate lanes indicating possible proteolytic events specific to B cells which is not seen in T cells.
( Figure 1) . In all cases the p120 signal was obvious in the immunoprecipitation lanes for primary T cells but not in primary B cells. The lysate in primary B cells showed a number of bands below the major p120 band indicating that there may be some degree of specificity for the cleaved forms of NOTCH1 in B cells. Similarly in T cells there were two specific bands that were recognized by the anti-NOTCH1 rabbit polyclonal antiserum (see Figure 5a-c) . It is possible that NOTCH1 is processed differently in B cells compared to T cells and the bands shown in the lysate lanes may represent specific processed forms of NOTCH1 in either cell types. Additionally, the levels of NOTCH1 seen in the primary B cell preparation are greater than that in the primary T cell preparation although these levels were similar in the B and T cell lines described previously.
The association of NOTCH1 with RBP-J is important and has a role in development of the organism. 34 The overexpression of intracellular truncated forms of NOTCH1 in mammalian cells is associated with the transformed phenotype. However, full length NOTCH1 does not transactivate Leukemia RBP-J responsive promoters or lead to a transformed state. 6 Therefore in primary cells the association of NOTCH1 and RBP-J is probably involved in the normal survival and differentiation of the cell. It is possible that promoters responsive to RBP-J activation through interactions with NOTCH1 would have greater activities in T cells than in B cell lines and that this activation will also be seen in B cell lines expressing EBNA2. Therefore, we decided to analyze transcription from the hairy enhancer of split promoter, a known cellular promoter responsive to RBP-J on activation by intracellular NOTCH1. 33 
Hairy enhancer of split (HES1) is induced in EBV infected B cells expressing EBNA2 and in T cells with increased levels of intracellular activated NOTCH1
In an effort to analyze the effects of intracellular NOTCH1 on EBV infected B cells or in T cells with increased levels of activated intracellular NOTCH1, we investigated the levels of a known downstream element CD23 affected by EBNA2 expression in B cells infected with EBV 35 for comparison with that of HES1, known to be activated by intracellular activated NOTCH1. For these analyses we isolated polyA mRNA from the BL41 cell line uninfected and infected with EBV and two infected LCLs, one long-term established cell line IB4 and a more recently established cell line LCL1 expressing high levels of EBNA2. The T cell lines were SupT1 that expresses high levels of activated NOTCH1 and Akr that expresses lower levels of activated NOTCH1. Figure 6b , B). This indicates that there was a definite difference in the expression of HES1 that is directly related to the levels of EBNA2 or NOTCH1 expressed (compare lanes 1, 2 and 6 with 3, 4 and 5 in Figure 6a, B and b, B) . We compared the levels of HES1 with levels of CD23 in these cells lines as a means of establishing a comparative basis for induction of downstream elements due to EBV infection, latent gene expression and transactivation of promoters through interaction with RBP-J. The data obtained suggest that in the EBV infected cells expressing EBNA2, the viral transactivator is capable of regulating the viral and cellular promoters through association with RBP-J. 14, 15, 24 As expected, CD23 is upregulated in EBV infected B cells Figure 6 ). Additionally, in EBV infected cells expressing the viral transactivator EBNA2, the cellular promoter that encodes the cognate sequence for RBP-J is activated similarly in B cells to that observed with activated
Leukemia
Figure 6
Northern blot analysis for determination of HES1 expression levels in B and T cells. Set a is the B cells and set b the T cells. In panel A, the nylon membrane was probed with 32 P-dCTP labeled with full length CD23 cDNA known to be upregulated in EBV infected B cells; panel B, the nylon was stripped and reprobed full length with HES1 cDNA; panel C, as before stripped and reprobed with labeled cDNA for GAPDH internal control. Signals were visualized by X-ray after exposure for 72 h at −80°C. The HES1 signal was quantitated and normalized to the levels of GAPDH shown in the boxes below the GAPDH signal. Numbers in boxes below represent arbitrary counts from the scanned X-ray analyzed by the Image Software (SCION).
NOTCH1 in T cells. The EBV transformed EBNA2 expressing cell lines IB4 and LCL1 showed a three-to four-fold increase in HES1 signal when normalized for GAPDH signal using arbitrary counts from the scanned X-ray film and NIH Image software. Moreover, there is a difference in the level of CD23 in BL41/B95-8 and IB4 suggesting differences in the potential activation of the CD23 promoter element that is based on EBNA2 and other latent genes including LMP1 which is expressed in IB4 and LCL1 involved in transactivation of this promoter. These data clearly demonstrate that HES1 signal is upregulated on expression of NOTCH1 and EBNA2. It is interesting to note that in a Northern blot for NOTCH1, no detectable increases in NOTCH1 expression were observed in EBV uninfected compared to infected B cells (data not shown) although HES1 levels are increased in EBV infected B cells expressing EBNA2 (Figure 6, panel B) .
It is possible that the downstream RBP-J responsive promoters are activated by NOTCH1 during specific temporally regulated events during differentiation. Therefore, the association of RBP-J and NOTCH1 in primary T cells is a normal event and only leads to a transformed phenotype when there is an overwhelming amount of intracellular truncated NOTCH1 expressed in cells continually driving the responsive promoters. The HES1 signals seen in Figure 6 may also be an indirect activation through other cellular factors not yet identified, but the fact that truncated forms of NOTCH1 can activate the HES1 promoter in an in vitro reporter assay 33 suggests that this may be a result of direct activation as seen in our Northern blots ( Figure 6 ) which has not been previously demonstrated.
Discussion
In these studies, we investigated the correlation between EBV infected transformed B cells and transformed T cells in which the NOTCH signaling pathway is utilized for the transforming events through the interaction of RBP-J with intracellular NOTCH1 (in T cells) or with EBV EBNA2 molecule (in B cells). Previous work demonstrated that both intracellular NOTCH1 and EBNA2 associate with RBP-J in cells activating both viral and cellular promoters. 5, 14, 15, 24 RBP-J interaction with EBNA2 is essential for EBV transformation of human primary B cells and the overexpression of intracellular NOTCH1 is crucial for T cell transformation through the translocation events of chromosomes 7 and 9. 5, 6, 27 These events increase the normal activity of the RBP-J-associated promoters by activation of these promoters, which under normal conditions are repressed. 23 However, it should be noted that full length NOTCH1 does not activate RBP-J responsive promoters and its expression is involved in development and differentiation of cells when triggered through ligand interaction. 5, 34 Hence, the transformed phenotype is most likely a result of constitutive activation of these responsive promoters that would otherwise be temporally regulated.
Numerous studies have established that the intracellular forms of NOTCH1 are oncogenic in T cell progenitors and exhibit 'gain-of-function' activities in the transformed cell lines. 5 The interaction of intracellular forms of NOTCH1 with RBP-J may contribute in part to the oncogenic nature of these molecules and other cellular interactions may have important roles in the initiation and maintenance of the oncogenic state leading to tumor development. The interaction of RBP-J with a number of EBV latent proteins crucial for EBV transformation of human primary B cells, resulting in the de-repression and/or regulation of promoters, may be critical points in the dysregulation of the normal activity of RBP-J leading to the development of the neoplastic state. However, it should be noted that a number of other EBV nuclear proteins bind to and alter RBP-J activity and that these proteins associate with RBP-J in EBV transformed primary B cells. 14, 15, 24, 28, 30, [36] [37] [38] [39] [40] [41] The ability of EBNA2 to compete with intracellular forms of NOTCH1 indicates that it is interacting with RBP-J on similar domains as seen by the abolition of RBP-J-mediated repression similar to EBNA2 in reporter assays. 23 This creates a scenario whereby EBNA2 can usurp the association of intracellular NOTCH1 with RBP-J interacting at promoters or in the cytoplasm. This makes it possible for EBV to transmit its influence on normal cell transcriptional control driving proliferation of primary B lymphocytes. Molecular genetics and recombinant virus studies demonstrated that a mutation in the two WW residues in EBNA2 essential for binding to RBP-J results in a null virus for primary B cell transformation. 27 Recent studies by Sakai et al 25 showed that EBNA2 and the cytoplasmic domain of NOTCH1 transactivates the cellular HES1 and another EBV promoter TP1 in COS7 cells. One of the questions raised by previous studies is the possibility that there are differences in the interactions between intracellular NOTCH1 and RBP-J occurring in B cells as compared to 293 or COS7 cells used in previously described experiments. This may be based on the available transcription factors recruited to the promoters in these cell lines. Hence, variations in the level of activation of promoters containing RBP-J binding sites can occur in B cells, 293T and COS7 cell lines. 5, 23, 25 Additional results from experiments in Drosophila suggest that a transient association of RBP-J and NOTCH1 results in transactivation of responsive promoters without NOTCH1 translocating to the nucleus. 34 Other factors like deltex that bind to the ankyrin repeats may influence NOTCH1 activity by displacing RBP-J from the ankyrin repeats, acting as a positive regulator. 34, [42] [43] [44] Most of the data so far propose a view that EBNA2 can substitute for NOTCH1 in activation of promoters. It was demonstrated that the interacting RAM domain of NOTCH1 can inhibit the activation of the TP1 and HES1 promoters and also compete with EBNA2 for binding to RBP-J. 23, 25 We have now directly demonstrated that with in vitro competition using GST fusion proteins of the intracellular form of NOTCH1 and GST-RBP-J we can strikingly compete intracellular NOTCH1 from binding RBP-J using EBNA2. EBNA2 competes with intracellular NOTCH1 from binding to GST-RBP-J as well as RBP-J from binding to GST-NOTCH1. Moreover, immunoprecipitation experiments using anti-NOTCH1 antiserum for detection of RBP-J complexed with NOTCH1 in B cells revealed some surprising results. Little or no RBP-J was seen by Western blotting using rabbit antiserum made against GST-RBP-J (aa 1-44). In the B cell lines infected with EBV no RBP-J was seen in co-immunoprecipitation experiments, whereas in the T cell lines RBP-J associate with NOTCH1. Using another antiserum against the intracellular domain of NOTCH1 to increase the possibility of detecting the association, similar results were obtained in uninfected as well as EBV infected B cells compared to the T cell lines by Western blot for RBP-J. Moreover, the reciprocal experiment also indicated a dramatic difference in the levels of NOTCH1 p120 fraction associated with RBP-J between B and T cells. Further investigations in human primary B and T cells revealed similar patterns of association with three different donors. This suggests that the distinctive difference in association of RBP-J and NOTCH1 is a major factor in the transformation events leading to establishment of the cell lines.
If EBNA2 can substitute for intracellular NOTCH1 we should be able to detect changes in expression levels of downstream molecules affected by increased levels of activated NOTCH1. We chose the HES1 gene transcription as a marker to detect increased activation of RBP-J responsive promoters. The CD23 B cell marker was used as a positive marker for EBNA2 and LMP1 expression in B cells due to increased levels of CD23 expression after EBV infection of human B lymphocytes. 35 We demonstrated that HES1 was induced in EBV infected B cell lines expressing EBNA2 similar to that seen in T cells with increased levels of activated NOTCH1. The increased levels of EBNA2 and LMP1 in the LCLs, IB4 and LCL1 correlate with increased CD23 expression suggesting a role for LMP1 in CD23 upregulation which is not necessarily reflective of that seen with HES1 induction in EBNA2 and NOTCH1 expressing cells. The reduced association between NOTCH1 and RBP-J in B cells is intriguing and may provide one possible explanation for the ability of EBV to effectively mediate transformation of human primary B cells.
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